🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of the fixe...
Status
Completed
Location
Research Center
Start Date
2006-06
Trial ID
NCT00393952
This is a Phase 3, randomized, placebo-controlled, double-blind,double-dumm...
Status
Completed
Location
Teva Investigational Site 10851
Start Date
2013-12
Trial ID
NCT02031640
Treatments Being Tested
This is a multi-center, randomized, double-blinded, placebo-controlled, cro...
Status
Completed
Location
West Coast Clinical Trials Global
Start Date
2012-10
Trial ID
NCT01737905
Treatments Being Tested
This is a randomized, multi-center, parallel-group, active-controlled, doub...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00394355
The purpose of this study is to assess the efficacy and safety of short rag...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-20
Trial ID
NCT02478398
Primary objective: To investigate the safety and local tolerability of incr...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT02220673
Treatments Being Tested
The purpose of this study is to investigate the efficacy of inhaled cicleso...
Status
Completed
Location
Altana Pharma/Nycomed
Start Date
2006-09
Trial ID
NCT00384189
Treatments Being Tested
The primary objective of this study is to evaluate the chronic-dose and eff...
Status
Completed
Location
Pediatric Care Medical Group, Inc.
Start Date
2007-08
Trial ID
NCT00577655
Treatments Being Tested
Primary objective To show the superiority of CHF 1535 (BDP/FF) pMDI (800/2...
Status
Completed
Location
Chiesi Clinical Trial Site
Start Date
2012-04-20
Trial ID
NCT01577082
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of beclomet...
Status
Completed
Location
Teva Investigational Site 13415
Start Date
2015-09-30
Trial ID
NCT02513160